National Health Act 1953 Determination under subsection 85B(1) (No. PB 5 of 2005) (Cth)
Case
COMMONWEALTH OF
National Health Act 1953
PHARMACEUTICAL BENEFITS
DETERMINATION UNDER SUBSECTION 85B(1)
No. PB 5 of 2005
I, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, pursuant to subsection 85B(1) of the National Health Act 1953 (referred to in this Determination as “the Act”), hereby make the following Determination:
This Determination commences on 1 April 2005.
The Determination under subsection 85B(1) of the Act made on 17 November 2004 with effect from 1 December 2004 is repealed.
In this Determination:
“authority prescription” means a prescription which directs the supply of a pharmaceutical benefit and is:
(a) a prescription authorised in accordance with paragraph 15 of the declaration made under subsection 85(2) of the Act; or
(b) a prescription authorised in accordance with paragraph 12 of the determinations made under sections 85, 85A and 88 of the Act; or
(c) a prescription authorised in accordance with subregulation 13(5) of the National Health (Pharmaceutical Benefits) Regulations 1960 made under the Act.
Section 85B of the Act applies in relation to each of the brands of the pharmaceutical benefits specified in Part A of the Schedule to this Determination (referred to in this Determination as “the Schedule”).
For the purposes of paragraph 85B(1)(c) of the Act, the quantity or number of units that is relevant for the purpose of determining an amount referred to in paragraph 85B (1) (d) or 85B(1)(e) of the Act in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the quantity or number of units specified in Part B of the Schedule in relation to the brand of the pharmaceutical benefit.
For the purposes of paragraph 85B(1)(d) of the Act, the amount that is, for the purposes of Part VII of the Act, to be taken to be the manufacturer’s price for sales to approved pharmacists in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the amount specified in Part C of the Schedule in relation to the brand of the pharmaceutical benefit.
For the purposes of paragraph 85B(1)(e) of the Act, the amount that is, for the purposes of Part VII of the Act, to be taken to be the price claimed by the manufacturer as the manufacturer’s price for sales to approved pharmacists in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the amount specified in Part D of the Schedule in relation to the brand of the pharmaceutical benefit.
The name of the manufacturer or the names of manufacturers denoted in accordance with the following table by letters appearing in the column headed “Brand” in Part A of the Schedule in relation to a pharmaceutical benefit specified in that Part of the Schedule is or are the brand or brands of the pharmaceutical benefit referred to in paragraphs 4, 5, 6 and 7:
| Letters | Manufacturer's Name | Letters | Manufacturer's Name |
| AB | Abbott Australasia Pty Ltd |
| AD | Amrad Pharmaceuticals Pty Ltd |
| AG | Allergan Australia Pty Ltd |
| | Alphapharm Medical A Division of Alphapharm Pty Limited |
| AP | AstraZeneca Pty Ltd |
| AQ | Alcon Laboratories ( |
| AS | Aspen Pharmacare Australia Pty Ltd |
| AV | Aventis Pharma Pty Limited |
| AW | Arrow Pharmaceuticals Limited |
| BN | Bayer Australia Limited |
| BP | British Pharmaceuticals |
| BQ | Bristol-Myers Squibb Pharmaceuticals A Division of Bristol-Myers Squibb Australia Pty Ltd |
| BX | Baxter Healthcare Pty Limited |
| BY | Boehringer Ingelheim Pty Limited |
| CS | CSL Limited |
| EX | |
| FR | Charles E. Frosst Division of Merck Sharp & Dohme ( |
| GC | GlaxoSmithKline Consumer Healthcare |
| GK | GlaxoSmithKline Australia Pty Ltd |
| ID | ICN Pharmaceuticals Australasia Pty Ltd |
| JC | Janssen-Cilag Pty Ltd |
| KN | Knoll A Division of Abbott Australasia Pty Ltd |
| LU | Lundbeck Australia Pty Ltd |
| LY | Eli Lilly Australia Pty Limited |
| MK | Merck Sharp & Dohme ( |
| MM | 3M Pharmaceuticals Australia Pty Ltd |
| MX | Mayne Pharma Pty Ltd |
| NV | Novartis Pharmaceuticals Australia Pty Ltd |
| OR | Organon ( |
| PF | Pfizer Pty Limited |
| PH | Pharmacia Australia Pty Limited |
| RO | Roche Products Pty Ltd |
| SC | Schering Pty Ltd Australian Subsidiary of Schering AG, |
| SE | Servier Laboratories (Aust.) Pty Ltd |
| SG | Serono Australia Pty Ltd |
| SI | Sigma Pharmaceuticals Pty Ltd |
| SM | Solvay Pharmaceuticals Division of Solvay Biosciences Pty Ltd |
| SU | Sauter Laboratories (Aust.) Pty Ltd |
| SW | Sanofi-Synthelabo Australia Pty Limited |
| SZ | Sandoz Pty Ltd |
| WR | Warner Lambert Consumer Healthcare Pty Ltd |
| WY | Wyeth Pharmaceuticals Division of Wyeth Australia Pty Limited |
| ZH | Shinnick Pharmaceuticals Pty Limited |
| Aciclovir | Tablet 200 mg | GK | 25 | 45.17 | 47.80 |
| GK | 90 | 165.31 | 169.20 | ||
| Tablet 800 mg | GK | 35 | 200.27 | 202.36 | |
| GK | 120 | 664.38 | 671.30 | ||
| Allopurinol | Tablet 100 mg | SI | 200 | 8.11 | 10.32 |
| Tablet 300 mg | SI | 60 | 4.80 | 6.87 | |
| Alprazolam | Tablet 250 micrograms | PH | 50 | 3.74 | 4.72 |
| Tablet 500 micrograms | PH | 50 | 6.05 | 7.11 | |
| Tablet 1 mg | PH | 50 | 10.56 | 11.79 | |
| Tablet 2 mg | PH | 50 | 16.33 | 17.83 | |
| Aluminium Hydroxide - Dried with Magnesium Hydroxide | Tablet 200 mg-200 mg | WR | 100 | 3.61 | 3.79 |
| Oral suspension 200 mg-200 mg per 5 mL, 500 mL | WR | 1 | 3.61 | 3.75 | |
| Amiodarone Hydrochloride | Tablet 100 mg | SW | 30 | 10.33 | 11.24 |
| Tablet 200 mg | SW | 30 | 18.36 | 19.27 | |
| Amitriptyline Hydrochloride | Tablet 25 mg | MK | 50 | 1.90 | 3.04 |
| Amlodipine Besylate | Tablet equivalent to 5 mg amlodipine (unless supplied on an authority prescription) | PF | 30 | 15.12 | 18.52 |
| Tablet equivalent to 10 mg amlodipine (unless supplied on an authority prescription) | PF | 30 | 25.98 | 31.29 | |
| Amoxycillin Trihydrate | Tablet equivalent to 1 g amoxycillin | SZ | 14 | 5.98 | 7.34 |
| GK | 14 | 5.98 | 7.34 | ||
| Capsule equivalent to 250 mg amoxycillin | GK | 20 | 2.91 | 3.82 | |
| Capsule equivalent to 500 mg amoxycillin | GK | 20 | 5.80 | 6.71 | |
| Amoxycillin Trihydrate with Potassium Clavulanate | Tablet equivalent to 500 mg amoxycillin-125 mg clavulanic acid | GK | 10 | 7.85 | 8.75 |
| Tablet equivalent to 875 mg amoxycillin-125 mg clavulanic acid | GK | 10 | 11.19 | 12.37 | |
| Amoxycillin Trihydrate with Potassium Clavulanate and Water - Purified BP | Powder for oral suspension equivalent to 125 mg amoxycillin-31.25 mg clavulanic acid per 5 mL, 75 mL | GK | 1 | 4.82 | 5.69 |
| Powder for oral suspension equivalent to 400 mg amoxycillin-57 mg clavulanic acid per 5 mL, 60 mL | GK | 1 | 6.89 | 7.78 | |
| Amoxycillin Trihydrate with Water - Purified BP | Powder for oral suspension equivalent to 125 mg amoxycillin per 5 mL, 100 mL | GK | 1 | 2.59 | 3.50 |
| Powder for oral suspension equivalent to 250 mg amoxycillin per 5 mL, 100 mL | GK | 1 | 3.74 | 4.65 | |
| Aspirin | Tablet 100 mg | MX | 112 | 1.46 | 2.70 |
| Atenolol | Tablet 50 mg | AP | 30 | 4.61 | 7.84 |
| Azathioprine | Tablet 25 mg | GK | 100 | 36.85 | 38.28 |
| Tablet 50 mg | GK | 100 | 62.73 | 64.09 | |
| Baclofen | Tablet 10 mg | NV | 100 | 30.73 | 33.45 |
| Tablet 25 mg | NV | 100 | 67.22 | 69.95 | |
| Betamethasone Valerate | Cream equivalent to 200 micrograms betamethasone per g, 100 g | SI | 1 | 3.89 | 5.07 |
| Cream equivalent to 500 micrograms betamethasone per g, 15 g | SI | 1 | 1.96 | 3.14 | |
| Ointment equivalent to 500 micrograms betamethasone per g, 15 g | SI | 1 | 1.96 | 3.14 | |
| Betaxolol Hydrochloride | Eye drops, solution, equivalent to 5 mg betaxolol per mL, 5 mL | AQ | 1 | 7.43 | 9.25 |
| Bleomycin Sulfate with any determined brand of sterilised Water for Injections or other solvent | Powder for injection 15,000 I.U. (with required solvent) | MX | 1 | 49.25 | 93.56 |
| BQ | 10 | 492.50 | 1,012.00 | ||
| ZH | 10 | 492.50 | 935.58 | ||
| Brimonidine Tartrate | Eye drops 2 mg per mL, 5 mL | AG | 1 | 12.80 | 14.16 |
| Brinzolamide | Eye drops 10 mg per mL, 5 mL | AQ | 1 | 12.80 | 13.26 |
| Bromocriptine Mesylate | Tablet equivalent to 2.5 mg bromocriptine | NV | 30 | 13.09 | 15.76 |
| NV | 60 | 26.17 | 28.90 | ||
| Capsule equivalent to 5 mg bromocriptine | NV | 60 | 51.46 | 54.19 | |
| Capsule equivalent to 10 mg bromocriptine | NV | 100 | 184.29 | 187.29 | |
| Captopril | Tablet 12.5 mg | BQ | 90 | 14.04 | 16.27 |
| Tablet 25 mg | BQ | 90 | 20.32 | 22.55 | |
| Tablet 50 mg | BQ | 90 | 40.10 | 42.33 | |
| Carbamazepine | Tablet 100 mg | NV | 200 | 15.24 | 17.05 |
| Tablet 200 mg | NV | 200 | 28.49 | 31.22 | |
| Carbomer 980 | Ocular lubricating gel 2 mg per g, 10 g | NV | 1 | 3.76 | 4.67 |
| Cefaclor Monohydrate | Tablet (sustained release) equivalent to 375 mg cefaclor | AS | 10 | 8.87 | 10.27 |
| Cefaclor Monohydrate with Water - Purified BP | Powder for oral suspension equivalent to 125 mg cefaclor per 5 mL, 100 mL | AS | 1 | 6.23 | 7.62 |
| Powder for oral suspension equivalent to 250 mg cefaclor per 5 mL, 75 mL | AS | 1 | 6.68 | 8.09 | |
| Cephalexin | Capsule 250 mg (anhydrous) | AS | 20 | 3.32 | 4.92 |
| Capsule 500 mg (anhydrous) | AS | 20 | 5.96 | 7.66 | |
| Cephalexin with Water - Purified BP | Granules for oral suspension 125 mg per 5 mL, 100 mL | AS | 1 | 3.95 | 5.57 |
| Granules for oral suspension 250 mg per 5 mL, 100 mL | AS | 1 | 5.87 | 7.57 | |
| Cephalothin Sodium with any determined brand of sterilised Water for Injections or other solvent | Injection equivalent to 1 g cephalothin, vial (with required solvent) | LY | 10 | 35.29 | 35.56 |
| Cephazolin Sodium with any determined brand of sterilised Water for Injections or other solvent | Injection equivalent to 1 g cephazolin, vial (with required solvent) | LY | 10 | 57.62 | 59.90 |
| Cimetidine | Tablet 200 mg | GK | 120 | 20.49 | 22.75 |
| Tablet 400 mg | GK | 60 | 20.49 | 22.75 | |
| Tablet 800 mg | GK | 30 | 20.49 | 25.00 | |
| Cimetidine Hydrochloride | Tablet, effervescent, equivalent to 800 mg cimetidine (unless supplied on an authority prescription) | GK | 30 | 20.49 | 26.86 |
| Ciprofloxacin Hydrochloride | Tablet equivalent to 250 mg ciprofloxacin | BN | 14 | 27.27 | 29.00 |
| Tablet equivalent to 500 mg ciprofloxacin | BN | 14 | 53.27 | 55.00 | |
| Tablet equivalent to 750 mg ciprofloxacin | BN | 14 | 80.27 | 82.00 | |
| Eye drops equivalent to 3 mg ciprofloxacin per mL, 5 mL | AQ | 1 | 10.53 | 11.65 | |
| Citalopram Hydrobromide | Tablet equivalent to 20 mg citalopram | LU | 28 | 24.09 | 27.00 |
| Clindamycin Hydrochloride | Capsule equivalent to 150 mg clindamycin | PH | 25 | 12.47 | 13.81 |
| Clomiphene Citrate | Tablet 50 mg | AV | 10 | 31.96 | 35.36 |
| SG | 10 | 31.96 | 32.13 | ||
| Clomipramine Hydrochloride | Tablet 25 mg | NV | 50 | 12.48 | 15.15 |
| Clonazepam | Tablet 500 micrograms | RO | 100 | 8.25 | 10.41 |
| Tablet 2 mg | RO | 100 | 15.52 | 17.95 | |
| Codeine Phosphate with Paracetamol | Tablet 30 mg-500 mg | SW | 20 | 2.27 | 3.71 |
| Colchicine | Tablet 500 micrograms | AS | 100 | 3.76 | 4.21 |
| Cyclosporin | Capsule 25 mg | NV | 30 | 46.25 | 47.34 |
| Capsule 50 mg | NV | 30 | 96.23 | 97.42 | |
| Capsule 100 mg | NV | 30 | 196.07 | 197.27 | |
| Cyproterone Acetate | Tablet 50 mg | SC | 20 | 57.62 | 58.98 |
| SC | 50 | 126.28 | 127.92 | ||
| Tablet 100 mg | SC | 50 | 204.59 | 205.59 | |
| Dexamethasone Sodium Metasulfobenzoate with Framycetin Sulfate and Gramicidin | Ear drops 500 micrograms (dexamethasone)-5 mg-50 micrograms per mL, 8 mL | AV | 1 | 2.14 | 3.50 |
| Diazepam | Tablet 2 mg | RO | 50 | 1.85 | 3.04 |
| SU | 50 | 1.85 | 2.68 | ||
| Tablet 5 mg | RO | 50 | 2.07 | 3.27 | |
| SU | 50 | 2.07 | 2.92 | ||
| Diclofenac Sodium | Tablet 25 mg (enteric coated) | NV | 50 | 3.98 | 5.48 |
| Tablet 50 mg (enteric coated) | NV | 50 | 5.54 | 8.45 | |
| Digoxin | Tablet 62.5 micrograms | SI | 200 | 3.42 | 4.60 |
| Tablet 250 micrograms | SI | 100 | 3.68 | 4.86 | |
| Diltiazem Hydrochloride | Tablet 60 mg | AV | 90 | 13.41 | 15.81 |
| Capsule 180 mg (controlled delivery) | AV | 30 | 14.88 | 17.28 | |
| Capsule 240 mg (controlled delivery) | AV | 30 | 20.09 | 22.49 | |
| Capsule 360 mg (controlled delivery) | AV | 30 | 24.73 | 27.64 | |
| Diphenoxylate Hydrochloride with Atropine Sulfate | Tablet 2.5 mg-25 micrograms | PH | 20 | 1.77 | 3.44 |
| Dothiepin Hydrochloride | Capsule 25 mg | AB | 50 | 2.39 | 3.36 |
| Tablet 75 mg | AB | 30 | 2.66 | 3.62 | |
| Doxepin Hydrochloride | Capsule equivalent to 10 mg doxepin | PF | 50 | 2.04 | 3.72 |
| Capsule equivalent to 25 mg doxepin | PF | 50 | 2.39 | 3.80 | |
| Doxycycline Hydrochloride | Tablet equivalent to 50 mg doxycycline | PF | 25 | 4.37 | 5.87 |
| Capsule equivalent to 50 mg doxycycline (containing enteric coated pellets) | MX | 25 | 4.37 | 5.93 | |
| Tablet equivalent to 100 mg doxycycline | PF | 7 | 2.44 | 3.89 | |
| Capsule equivalent to 100 mg doxycycline (containing enteric coated pellets) | MX | 7 | 2.44 | 3.82 | |
| MX | 21 | 7.31 | 9.81 | ||
| Enalapril Maleate | Tablet 5 mg | AD | 30 | 9.19 | 11.42 |
| MK | 30 | 9.19 | 12.05 | ||
| Tablet 10 mg | AD | 30 | 15.09 | 17.32 | |
| MK | 30 | 15.09 | 17.95 | ||
| Tablet 20 mg | AD | 30 | 19.22 | 21.45 | |
| MK | 30 | 19.22 | 22.08 | ||
| Erythromycin | Capsule 250 mg (containing enteric coated pellets) | MX | 25 | 4.13 | 5.22 |
| Erythromycin Ethyl Succinate | Tablet equivalent to 400 mg erythromycin | AB | 25 | 3.78 | 6.41 |
| Erythromycin Ethyl Succinate with Water - Purified BP | Powder for oral liquid equivalent to 200 mg erythromycin per 5 mL, 100 mL | AB | 1 | 3.40 | 5.39 |
| Powder for oral liquid equivalent to 400 mg erythromycin per 5 mL, 100 mL | AB | 1 | 5.10 | 6.69 | |
| Famotidine | Tablet 20 mg | AD | 60 | 15.06 | 19.98 |
| MK | 60 | 15.06 | 19.98 | ||
| Tablet 40 mg | AD | 30 | 15.06 | 19.98 | |
| MK | 30 | 15.06 | 19.98 | ||
| Felodipine | Tablet 2.5 mg (extended release) | AP | 30 | 9.67 | 12.40 |
| Tablet 5 mg (extended release) | AP | 30 | 13.30 | 16.35 | |
| Tablet 10 mg (extended release) | AP | 30 | 23.81 | 28.04 | |
| Flecainide Acetate | Tablet 100 mg | MM | 60 | 37.84 | 40.44 |
| Flucloxacillin Magnesium with Water - Purified BP | Powder for oral suspension equivalent to 125 mg flucloxacillin per 5 mL, 100 mL | GK | 1 | 5.42 | 5.47 |
| Powder for oral suspension equivalent to 250 mg flucloxacillin per 5 mL, 100 mL | GK | 1 | 8.81 | 8.90 | |
| Flucloxacillin Sodium | Capsule equivalent to 250 mg flucloxacillin | GK | 24 | 6.02 | 6.44 |
| Capsule equivalent to 500 mg flucloxacillin | GK | 24 | 12.61 | 13.14 | |
| Fluoxetine Hydrochloride | Tablet, dispersible, equivalent to 20 mg fluoxetine | LY | 28 | 23.75 | 27.48 |
| Capsule equivalent to 20 mg fluoxetine | LY | 28 | 23.75 | 27.48 | |
| Flutamide | Tablet 250 mg | EX | 100 | 198.89 | 248.28 |
| Fluvoxamine Maleate | Tablet 50 mg | SM | 30 | 19.10 | 20.55 |
| Tablet 100 mg | SM | 30 | 28.93 | 30.38 | |
| Frusemide | Tablet 20 mg | AV | 50 | 1.56 | 2.07 |
| Tablet 40 mg | AV | 100 | 2.83 | 3.84 | |
| Tablet 500 mg | AV | 50 | 14.76 | 19.01 | |
| Gemfibrozil | Tablet 600 mg | PF | 60 | 31.85 | 35.03 |
| Glibenclamide | Tablet 5 mg | AV | 100 | 4.83 | 5.96 |
| Gliclazide | Tablet 80 mg | SE | 100 | 9.71 | 10.94 |
| Glimepiride | Tablet 1 mg | AV | 30 | 3.66 | 5.74 |
| Tablet 2 mg | AV | 30 | 7.00 | 9.09 | |
| Tablet 3 mg | AV | 30 | 9.00 | 11.09 | |
| Tablet 4 mg | AV | 30 | 11.00 | 13.09 | |
| Glipizide | Tablet 5 mg | PH | 100 | 4.93 | 8.65 |
| Glyceryl Trinitrate | Tablets 600 micrograms, 100 | SI | 1 | 2.87 | 4.05 |
| Hydrochlorothiazide with Amiloride Hydrochloride | Tablet 50 mg-5 mg | MK | 50 | 2.91 | 4.47 |
| Hydrocortisone Acetate | Cream 10 mg per g, 30 g | SI | 1 | 1.67 | 2.85 |
| Cream 10 mg per g, 50 g | SI | 1 | 2.09 | 3.27 | |
| Ointment 10 mg per g, 30 g | SI | 1 | 1.67 | 2.85 | |
| Ointment 10 mg per g, 50 g | SI | 1 | 2.09 | 3.27 | |
| Hypromellose | Eye drops 3 mg per mL, 15 mL | NV | 1 | 3.76 | 5.45 |
| Hypromellose with Carbomer 980 | Ocular lubricating gel 3 mg-2 mg per g, 10 g | NV | 1 | 3.76 | 5.45 |
| Hypromellose 4500 with Dextran 70 | Eye drops 3 mg-1 mg per mL, 15 mL | AQ | 1 | 5.40 | 6.92 |
| Indapamide Hemihydrate | Tablet 2.5 mg | SE | 90 | 13.25 | 16.32 |
| Indomethacin | Capsule 25 mg | MK | 50 | 1.81 | 3.20 |
| Ipratropium Bromide | Nebuliser solution 250 micrograms (anhydrous) in 1 mL single dose units, 30 | BY | 1 | 21.13 | 21.56 |
| Nebuliser solution 500 micrograms (anhydrous) in 1 mL single dose units, 30 | BY | 1 | 24.97 | 25.39 | |
| Iron Polymaltose Complex | Injection 100 mg (iron) in 2 mL ampoule | BX | 5 | 43.30 | 44.41 |
| Isosorbide Dinitrate | Tablet 10 mg | SI | 100 | 3.40 | 5.08 |
| Isosorbide Mononitrate | Tablet 60 mg (sustained release) | AP | 30 | 7.74 | 10.33 |
| Tablet 120 mg (sustained release) | AP | 30 | 18.35 | 21.08 | |
| Isotretinoin | Capsule 20 mg | RO | 60 | 131.69 | 133.96 |
| Ketoprofen | Capsule 200 mg (sustained release) | AV | 28 | 9.63 | 11.26 |
| Labetalol Hydrochloride | Tablet 100 mg | SI | 100 | 8.11 | 10.69 |
| Tablet 200 mg | SI | 100 | 14.10 | 16.80 | |
| Lactulose | Solution BP 3.34 g per 5 mL, 500 mL | SM | 1 | 9.36 | 11.36 |
| Lamotrigine | Tablet 25 mg | GK | 56 | 33.40 | 34.31 |
| Tablet 50 mg | GK | 56 | 55.70 | 56.61 | |
| Tablet 100 mg | GK | 56 | 92.80 | 93.71 | |
| Tablet 200 mg | GK | 56 | 155.90 | 156.81 | |
| Leflunomide | Tablet 10 mg | AV | 30 | 99.55 | 100.66 |
| Tablet 20 mg | AV | 30 | 151.58 | 152.69 | |
| Lercanidipine Hydrochloride | Tablet 10 mg (unless supplied on an authority prescription) | SM | 30 | 18.38 | 19.84 |
| Tablet 20 mg (unless supplied on an authority prescription) | SM | 30 | 29.63 | 32.54 | |
| Levodopa with Carbidopa | Tablet 100 mg-25 mg (anhydrous) | MK | 100 | 31.05 | 35.97 |
| Tablet 250 mg-25 mg (anhydrous) | MK | 100 | 38.29 | 41.20 | |
| Levonorgestrel with Ethinyloestradiol | Tablets 150 micrograms-30 micrograms, 21 | SC | 1 | 2.40 | 4.62 |
| Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets | SC | 1 | 2.40 | 4.62 | |
| WY | 1 | 2.40 | 4.50 | ||
| Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms and 10 tablets 125 micrograms-30 micrograms | SC | 1 | 2.40 | 4.62 | |
| Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets | SC | 1 | 2.40 | 4.62 | |
| WY | 1 | 2.40 | 4.50 | ||
| Lisinopril | Tablet 5 mg | AP | 30 | 10.54 | 12.49 |
| MK | 30 | 10.54 | 12.31 | ||
| Tablet 10 mg | AP | 30 | 15.84 | 17.79 | |
| MK | 30 | 15.84 | 17.61 | ||
| Tablet 20 mg | AP | 30 | 19.94 | 21.89 | |
| MK | 30 | 19.94 | 21.71 | ||
| Loperamide Hydrochloride | Capsule 2 mg | JC | 12 | 1.77 | 2.61 |
| Medroxyprogesterone Acetate | Tablet 10 mg | PH | 100 | 23.65 | 25.15 |
| Tablet 5 mg | PH | 56 | 8.06 | 9.67 | |
| Tablet 10 mg | PH | 30 | 8.64 | 10.25 | |
| Injection 150 mg in 1 mL vial | PH | 1 | 7.53 | 10.58 | |
| Meloxicam | Tablet 7.5 mg | BY | 30 | 17.36 | 19.03 |
| Tablet 15 mg | BY | 30 | 25.31 | 26.98 | |
| Metformin Hydrochloride | Tablet 500 mg | | 100 | 9.13 | 10.76 |
| AW | 100 | 9.13 | 10.41 | ||
| Tablet 850 mg | | 60 | 9.13 | 10.76 | |
| AW | 60 | 9.13 | 10.41 | ||
| Methotrexate | Tablet 2.5 mg | WY | 30 | 6.53 | 6.60 |
| Methyldopa | Tablet 250 mg | MK | 100 | 5.10 | 7.55 |
| Methylprednisolone Acetate | Injection 40 mg in 1 mL vial | PH | 5 | 16.87 | 17.55 |
| Metoclopramide Hydrochloride | Tablet 10 mg | ID | 25 | 1.46 | 4.17 |
| Metoprolol Tartrate | Tablet 50 mg | AP | 100 | 5.29 | 8.25 |
| NV | 100 | 5.29 | 7.56 | ||
| Tablet 100 mg | AP | 60 | 6.72 | 9.67 | |
| NV | 60 | 6.72 | 8.99 | ||
| Metronidazole | Tablet 400 mg | AV | 21 | 4.32 | 6.20 |
| Tablet 200 mg | AV | 21 | 1.84 | 3.64 | |
| Mianserin Hydrochloride | Tablet 10 mg | OR | 50 | 8.73 | 9.90 |
| Tablet 20 mg | OR | 50 | 18.43 | 19.88 | |
| Minocycline Hydrochloride | Tablet equivalent to 50 mg minocycline | SI | 60 | 10.87 | 11.89 |
| Mirtazapine | Tablet 30 mg | BP | 30 | 28.64 | 29.77 |
| OR | 30 | 28.64 | 49.33 | ||
| Moclobemide | Tablet 150 mg | RO | 60 | 19.89 | 20.75 |
| Tablet 300 mg | RO | 60 | 39.77 | 41.53 | |
| Naproxen | Tablet 250 mg | RO | 50 | 4.37 | 5.78 |
| Tablet 500 mg | RO | 50 | 7.77 | 9.41 | |
| Tablet 750 mg (sustained release) | RO | 28 | 7.14 | 8.66 | |
| Tablet 1 g (sustained release) | RO | 28 | 9.52 | 11.13 | |
| Naproxen Sodium | Tablet 550 mg | RO | 50 | 8.01 | 10.74 |
| Nifedipine | Tablet 10 mg | BN | 60 | 12.92 | 14.54 |
| Tablet 20 mg | BN | 60 | 16.10 | 19.11 | |
| Tablet 20 mg (controlled release) (unless supplied on an authority prescription) | BN | 30 | 16.04 | 18.04 | |
| Tablet 30 mg (controlled release) | BN | 30 | 17.31 | 20.13 | |
| Tablet 60 mg (controlled release) | BN | 30 | 21.76 | 25.13 | |
| Nitrazepam | Tablet 5 mg | ID | 25 | 1.76 | 3.60 |
| Nizatidine | Capsule 150 mg | AS | 60 | 16.64 | 19.00 |
| Capsule 300 mg | AS | 30 | 16.64 | 19.00 | |
| Norethisterone | Tablets 350 micrograms, 28 | PH | 1 | 2.40 | 3.31 |
| Norethisterone with Ethinyloestradiol | Tablets 500 micrograms-35 micrograms, 21 | PH | 1 | 2.40 | 4.21 |
| Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets | PH | 1 | 2.40 | 4.21 | |
| Tablets 1 mg-35 micrograms, 21 | PH | 1 | 2.40 | 4.21 | |
| Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets | PH | 1 | 2.40 | 4.21 | |
| Pack containing 12 tablets 500 micrograms-35 micrograms, 9 tablets 1 mg-35 micrograms and 7 inert tablets | PH | 1 | 2.40 | 4.21 | |
| Norfloxacin | Tablet 400 mg | FR | 14 | 13.54 | 15.11 |
| MK | 14 | 13.54 | 16.93 | ||
| Omeprazole Magnesium | Tablet equivalent to 20 mg omeprazole | AP | 30 | 34.37 | 36.19 |
| Oxazepam | Tablet 15 mg | SI | 25 | 1.17 | 2.48 |
| Tablet 30 mg | SI | 25 | 1.36 | 2.68 | |
| Paracetamol | Tablet 665 mg (modified release) | GC | 96 | 3.51 | 5.73 |
| Paraffin - Soft White with Paraffin - Liquid | Eye ointment, compound, 3.5 g | AQ | 1 | 6.06 | 6.97 |
| Pack containing 2 tubes eye ointment, compound, 3.5 g | AG | 1 | 12.13 | 13.95 | |
| Paroxetine Hydrochloride | Tablet equivalent to 20 mg paroxetine | GK | 30 | 27.01 | 28.01 |
| Phenoxymethylpenicillin Benzathine | Oral suspension equivalent to 125 mg phenoxymethylpenicillin per 5 mL, 100 mL | SI | 1 | 3.45 | 4.11 |
| Oral suspension equivalent to 250 mg phenoxymethylpenicillin per 5 mL, 100 mL | SI | 1 | 4.71 | 5.37 | |
| Pilocarpine Hydrochloride | Eye drops 5 mg per mL, 15 mL | AG | 1 | 5.18 | 7.00 |
| Eye drops 10 mg per mL, 15 mL | AG | 1 | 5.18 | 7.00 | |
| Eye drops 20 mg per mL, 15 mL | AG | 1 | 6.23 | 8.15 | |
| Eye drops 30 mg per mL, 15 mL | AG | 1 | 8.64 | 11.00 | |
| Eye drops 40 mg per mL, 15 mL | AG | 1 | 8.64 | 11.00 | |
| Eye drops 60 mg per mL, 15 mL | AG | 1 | 12.45 | 14.25 | |
| Pindolol | Tablet 5 mg | NV | 100 | 6.07 | 8.62 |
| Tablet 15 mg | NV | 50 | 8.73 | 11.27 | |
| Piperazine Oestrone Sulfate | Tablet 730 micrograms | PH | 56 | 5.11 | 6.45 |
| Tablet 1.46 mg | PH | 56 | 6.94 | 8.29 | |
| Piroxicam | Dispersible tablet 10 mg | PF | 50 | 7.29 | 9.79 |
| Dispersible tablet 20 mg | PF | 25 | 6.92 | 9.40 | |
| Capsule 10 mg | PF | 50 | 7.29 | 9.79 | |
| Capsule 20 mg | PF | 25 | 6.92 | 9.40 | |
| Polyvinyl Alcohol | Eye drops 14 mg per mL, 15 mL | AG | 1 | 3.98 | 5.31 |
| Eye drops 30 mg per mL, 15 mL | AG | 1 | 5.82 | 9.20 | |
| Potassium Chloride | Tablet 600 mg (sustained release) | NV | 100 | 2.71 | 3.80 |
| Potassium Chloride with Potassium Bicarbonate | Tablet, effervescent, 14 mmol K+ and 8 mmol Cl- | AS | 60 | 5.54 | 7.93 |
| Prazosin Hydrochloride | Tablet equivalent to 1 mg prazosin | PF | 100 | 7.43 | 10.20 |
| Tablet equivalent to 2 mg prazosin | PF | 100 | 10.19 | 13.05 | |
| Tablet equivalent to 5 mg prazosin | PF | 100 | 17.29 | 20.38 | |
| Prednisolone | Tablet 1 mg | AS | 100 | 2.15 | 2.72 |
| Prednisolone Sodium Phosphate | Oral solution equivalent to 5 mg prednisolone per mL, 30 mL | AS | 1 | 7.30 | 8.50 |
| Prednisone | Tablet 1 mg | AS | 100 | 2.15 | 2.72 |
| Prochlorperazine Maleate | Tablet 5 mg | AV | 25 | 2.36 | 4.14 |
| Propranolol Hydrochloride | Tablet 10 mg | AP | 100 | 1.24 | 3.96 |
| Tablet 40 mg | AP | 100 | 2.43 | 5.15 | |
| Quinine Sulfate | Tablet 300 mg | AS | 50 | 4.70 | 6.69 |
| Ramipril | Tablet 1.25 mg | AV | 30 | 8.05 | 9.87 |
| Tablet 2.5 mg | AV | 30 | 11.68 | 13.51 | |
| Tablet 5 mg | AV | 30 | 14.57 | 16.39 | |
| Capsule 10 mg (unless supplied on an authority prescription) | AV | 30 | 25.57 | 26.80 | |
| Ranitidine Hydrochloride | Tablet equivalent to 150 mg ranitidine | GK | 60 | 15.69 | 17.66 |
| Tablet, effervescent, equivalent to 150 mg ranitidine (unless supplied on an authority prescription) | GK | 30 | 7.85 | 8.83 | |
| Tablet equivalent to 300 mg ranitidine | GK | 30 | 15.69 | 17.66 | |
| Syrup equivalent to 150 mg ranitidine per 10 mL, 300 mL (unless supplied on an authority prescription) | GK | 1 | 7.85 | 8.83 | |
| Roxithromycin | Tablet 150 mg | AV | 10 | 7.30 | 9.36 |
| Tablet 300 mg | AV | 5 | 7.30 | 9.36 | |
| Salbutamol Sulfate | Pressurised inhalation equivalent to 100 micrograms salbutamol per dose, 200 doses (CFC-free formulation) | GK | 1 | 5.28 | 5.74 |
| MM | 1 | 5.28 | 5.56 | ||
| Nebuliser solution equivalent to 2.5 mg salbutamol in 2.5 mL single dose units, 30 | GK | 1 | 8.57 | 9.57 | |
| Nebuliser solution equivalent to 5 mg salbutamol in 2.5 mL single dose units, 30 | GK | 1 | 9.06 | 10.06 | |
| Sertraline Hydrochloride | Tablet equivalent to 50 mg sertraline | PF | 30 | 26.90 | 27.40 |
| Tablet equivalent to 100 mg sertraline | PF | 30 | 26.90 | 27.40 | |
| Simvastatin | Tablet 10 mg | AD | 30 | 31.93 | 32.56 |
| MK | 30 | 31.93 | 32.56 | ||
| Tablet 20 mg | AD | 30 | 45.90 | 46.54 | |
| MK | 30 | 45.90 | 46.54 | ||
| Tablet 40 mg | AD | 30 | 66.06 | 66.70 | |
| MK | 30 | 66.06 | 66.70 | ||
| Tablet 80 mg | AD | 30 | 94.91 | 95.55 | |
| MK | 30 | 94.91 | 95.55 | ||
| Sodium Valproate | Tablet 200 mg (enteric coated) | SW | 100 | 14.38 | 14.98 |
| Tablet 500 mg (enteric coated) | SW | 100 | 28.45 | 29.20 | |
| Sotalol Hydrochloride | Tablet 80 mg | BQ | 60 | 11.21 | 12.72 |
| Tablet 160 mg | BQ | 60 | 24.05 | 25.69 | |
| Spironolactone | Tablet 25 mg | PH | 100 | 7.28 | 9.00 |
| Tablet 100 mg | PH | 100 | 28.63 | 31.01 | |
| Sucralfate | Tablet equivalent to 1 g anhydrous sucralfate | AS | 120 | 16.49 | 18.50 |
| Sulfasalazine | Tablet 500 mg (enteric coated) | PH | 100 | 24.27 | 25.02 |
| Tamoxifen Citrate | Tablet equivalent to 10 mg tamoxifen | AP | 30 | 19.45 | 20.44 |
| Tablet equivalent to 20 mg tamoxifen | AP | 30 | 33.71 | 35.50 | |
| Temazepam | Tablet 10 mg | SI | 25 | 1.76 | 2.73 |
| Terbinafine Hydrochloride | Tablet equivalent to 250 mg terbinafine | NV | 42 | 138.00 | 139.82 |
| Thyroxine Sodium | Tablet equivalent to 50 micrograms anhydrous thyroxine sodium | SI | 200 | 7.84 | 9.02 |
| Tablet equivalent to 100 micrograms anhydrous thyroxine sodium | SI | 200 | 8.87 | 10.05 | |
| Tablet equivalent to 200 micrograms anhydrous thyroxine sodium | SI | 200 | 10.89 | 12.07 | |
| Ticlopidine Hydrochloride | Tablet 250 mg | RO | 60 | 134.27 | 136.33 |
| Timolol Maleate | Eye drops equivalent to 2.5 mg timolol per mL, 5 mL | FR | 1 | 6.44 | 7.43 |
| Eye drops equivalent to 5 mg timolol per mL, 5 mL | FR | 1 | 7.43 | 8.47 | |
| Tinidazole | Tablet 500 mg | PF | 4 | 2.56 | 4.84 |
| Tramadol Hydrochloride | Capsule 50 mg | CS | 20 | 3.75 | 4.30 |
| Tablet 100 mg (sustained release) | CS | 20 | 10.19 | 10.91 | |
| Tablet 150 mg (sustained release) | CS | 20 | 13.74 | 14.47 | |
| Tablet 200 mg (sustained release) | CS | 20 | 16.72 | 17.44 | |
| Trandolapril | Capsule 500 micrograms | KN | 28 | 8.95 | 9.86 |
| Capsule 1 mg | KN | 28 | 14.24 | 15.15 | |
| Capsule 2 mg | KN | 28 | 15.84 | 16.74 | |
| Triamcinolone Acetonide | Cream 200 micrograms per g, 100 g | SI | 1 | 3.89 | 5.07 |
| Ointment 200 micrograms per g, 100 g | SI | 1 | 3.89 | 5.07 | |
| Triamcinolone Acetonide with Neomycin Sulfate, Gramicidin and Nystatin | Ear drops 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 7.5 mL | BQ | 1 | 2.14 | 3.14 |
| Ear ointment 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 5 g | BQ | 1 | 1.70 | 2.70 | |
| Trimethoprim | Tablet 300 mg | SI | 7 | 2.47 | 3.71 |
| Trimethoprim with Sulfamethoxazole | Tablet 80 mg-400 mg | SI | 10 | 2.70 | 4.10 |
| Tablet 160 mg-800 mg | SI | 10 | 3.55 | 4.88 | |
| Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL | SI | 1 | 3.16 | 4.90 | |
| Vancomycin Hydrochloride with any determined brand of sterilised Water for Injections or other solvent | Injection equivalent to 500 mg (500,000 I.U.) vancomycin activity (with required solvent) | LY | 1 | 21.44 | 21.60 |
| Verapamil Hydrochloride | Tablet 40 mg | AB | 100 | 6.10 | 7.01 |
| Tablet 80 mg | AB | 100 | 10.83 | 11.74 | |
| Tablet 120 mg | AB | 100 | 15.70 | 16.61 | |
| Tablet 180 mg (sustained release) | AB | 30 | 8.74 | 11.46 | |
| Tablet 240 mg (sustained release) | AB | 30 | 11.65 | 14.38 |
Dated this twenty second day of March 2005.
| JOAN CORBETT Assistant Secretary Pharmaceutical Benefits Branch Department of Health and Ageing Delegate of the Minister for Health and Ageing |
Actions
Download as PDF
Download as Word Document
Cases Citing This Decision
0
Cases Cited
0
Statutory Material Cited
0